A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments

The DNA damage response kinase ATR may be a useful cancer therapeutic target. ATR inhibition synergizes with loss of ERCC1, ATM, XRCC1 and DNA damaging chemotherapy agents. Clinical trials have begun using ATR inhibitors in combination with cisplatin. Here we report the first synthetic lethality scr...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:PLoS One
Huvudupphovsmän: Mohni, Kareem N., Thompson, Petria S., Luzwick, Jessica W., Glick, Gloria G., Pendleton, Christopher S., Lehmann, Brian D., Pietenpol, Jennifer A., Cortez, David
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2015
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4428765/
https://ncbi.nlm.nih.gov/pubmed/25965342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0125482
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk